• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up0.12% Nasdaq Up0.71%

    Amicus Therapeutics, Inc. (FOLD)

    -NasdaqGM
    12.25 Down 0.05(0.41%) Apr 24, 4:00PM EDT
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2014Sep 30, 2014Jun 30, 2014Mar 31, 2014
    Total Revenue -   293   475   456  
    Cost of Revenue -   -   -   -  
    Gross Profit -   293   475   456  
    Operating Expenses
    Research Development15,605  12,049  9,978  9,992  
    Selling General and Administrative6,018  4,670  4,448  5,681  
    Non Recurring11  15  (81)(8)
    Others364  375  396  412  
    Total Operating Expenses21,998  17,109  14,741  16,077  
    Operating Income or Loss (21,998) (16,816) (14,266) (15,621)
    Income from Continuing Operations
    Total Other Income/Expenses Net43  44  26  33  
    Earnings Before Interest And Taxes(21,955)(16,772)(14,240)(15,588)
    Interest Expense378  377  374  355  
    Income Before Tax(22,333)(17,149)(14,614)(15,943)
    Income Tax Expense(1,113) -   -   -  
    Minority Interest -   -   -   -  
    Net Income From Continuing Ops(21,220)(17,149)(14,614)(15,943)
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income (21,220) (17,149) (14,614) (15,943)
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares (21,220) (17,149) (14,614) (15,943)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.